Safeguard Scientifics (SFE) Upgraded to “Buy” by Zacks Investment Research
Safeguard Scientifics (NYSE:SFE) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Friday. The firm currently has a $14.00 target price on the asset manager’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 12.45% from the company’s current price.
According to Zacks, “Safeguard Scientifics, Inc. is a diversified information technology company that develops, operates and manages emerging growth information technology companies. The company is currently focusing on emerging opportunities in eCommerce, enterprise applications, and network infrastructure, all of which are expected to benefit from the growing use of the Internet as a fundamental business tool. The company works closely with our partnership companies to provide numerous operational and management services to build value in preparation for public rights offerings and beyond. “
Other equities analysts have also recently issued reports about the stock. Keefe, Bruyette & Woods reissued a “mkt perform” rating and issued a $13.25 target price on shares of Safeguard Scientifics in a research note on Wednesday, December 6th. ValuEngine cut shares of Safeguard Scientifics from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th.
Several large investors have recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp grew its stake in shares of Safeguard Scientifics by 0.5% in the second quarter. Bank of New York Mellon Corp now owns 101,819 shares of the asset manager’s stock valued at $1,212,000 after buying an additional 469 shares in the last quarter. Parametric Portfolio Associates LLC grew its stake in shares of Safeguard Scientifics by 3.1% in the second quarter. Parametric Portfolio Associates LLC now owns 17,132 shares of the asset manager’s stock valued at $204,000 after buying an additional 513 shares in the last quarter. Schwab Charles Investment Management Inc. grew its stake in shares of Safeguard Scientifics by 0.7% in the second quarter. Schwab Charles Investment Management Inc. now owns 87,327 shares of the asset manager’s stock valued at $1,040,000 after buying an additional 570 shares in the last quarter. Nationwide Fund Advisors grew its stake in shares of Safeguard Scientifics by 7.6% in the second quarter. Nationwide Fund Advisors now owns 14,195 shares of the asset manager’s stock valued at $169,000 after buying an additional 1,006 shares in the last quarter. Finally, Voya Investment Management LLC grew its stake in shares of Safeguard Scientifics by 12.8% in the second quarter. Voya Investment Management LLC now owns 16,710 shares of the asset manager’s stock valued at $199,000 after buying an additional 1,896 shares in the last quarter. 76.46% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “Safeguard Scientifics (SFE) Upgraded to “Buy” by Zacks Investment Research” was first posted by Daily Political and is owned by of Daily Political. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://www.dailypolitical.com/2018/02/09/safeguard-scientifics-sfe-upgraded-to-buy-by-zacks-investment-research.html.
About Safeguard Scientifics
Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.